(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.47%) $83.46
(-1.16%) $1.619
(0.00%) $2 347.20
(0.85%) $27.49
(0.37%) $925.50
(-0.05%) $0.934
(-0.08%) $11.02
(-0.08%) $0.800
(0.00%) $92.17
Live Chart Being Loaded With Signals
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome...
Stats | |
---|---|
今日成交量 | 55 054.00 |
平均成交量 | 619 185 |
市值 | 629 353 |
EPS | $0 ( 2024-03-14 ) |
下一个收益日期 | ( $-2.31 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0700 |
ATR14 | $0.00300 (0.47%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-26 | Sember Michael T | Buy | 7 652 | Share Option (Right to Buy) |
2023-10-26 | Dunn Gordon | Buy | 51 149 | Share Option (Right to Buy) |
2023-10-26 | Myers Michael | Buy | 80 965 | Share Option (Right to Buy) |
2023-10-26 | Culverwell Anthony James | Buy | 7 652 | Share Option (Right to Buy) |
2023-10-26 | Cooper Joseph Patrick | Buy | 7 652 | Share Option (Right to Buy) |
INSIDER POWER |
---|
-99.96 |
Last 24 transactions |
Buy: 251 340 | Sell: 1 792 856 400 |
音量 相关性
Quoin Pharmaceuticals, 相关性
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Quoin Pharmaceuticals, 相关性 - 货币/商品
Quoin Pharmaceuticals, 财务报表
Annual | 2023 |
营收: | $0 |
毛利润: | $-103 438 (0.00 %) |
EPS: | $-9.62 |
FY | 2023 |
营收: | $0 |
毛利润: | $-103 438 (0.00 %) |
EPS: | $-9.62 |
FY | 2022 |
营收: | $0 |
毛利润: | $-103 635 (0.00 %) |
EPS: | $-22.97 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-30.71 |
Financial Reports:
No articles found.
Quoin Pharmaceuticals,
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。